Aripiprazole Impurity 5
Product Description
CAT No.
ALN-A001035
CAS No.
52749-50-5
Mol. F.
C9H9NO2
Mol. Wt.
163.2
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 8-Hydroxy-3,4-dihydro-2(1H)-quinolinone; 3,4-Dihydro-8-hydroxy-2(1H)-quinolinone; 8-Hydroxy-hydrocarbostyril; 3,4-Dihydro-8-hydroxy-1H-quinolin-2-one; 3,4-Dihydro-8-hydroxycarbostyril; 8-Hydroxy-1,2,3,4-tetrahydro-2-quinolinone; 8-Hydroxy-3,4-dihydro-2(1H)-quinolinone; 8-Hydroxy-3,4-dihydrocarbostyril;
Smiles : OC1=C2C(CCC(N2)=O)=CC=C1
Inchi : InChI=1S/C36H42Cl2N4O4/c37-30-6-5-7-32(36(30)38)41-20-18-40(19-21-41)16-1-3-22-46-29-13-9-27-11-15-35(44)42(33(27)25-29)17-2-4-23-45-28-12-8-26-10-14-34(43)39-31(26)24-28/h5-9,12-13,24-25H,1-4,10-11,14-23H2,(H,39,43)
Technical Data
Reference
Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and In vivo studies
Haley McFall1 , Sandeep Sarabu1 , Vijaykumar Shankar1 , Suresh Bandari1 , S. Narasimha Murthy1 , Karl Kolter2 , Nigel Langley3 , Dong Wuk Kim4**, Michael A. RepkanInternational Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311
Molecular determinants of the intrinsic efficacy of the antipsychotic aripiprazole
Identification of Degradation Impurities in Aripiprazole Oral Solution Using LC-MS and Development of Validated Stability Indicating Method for Assay and Content of Two Preservatives by RP-HPLC
, Michael A. Repka – International Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311
RFQ